Main Article Content
Background: Burkholderia cepacia, an aerobic gram-negative bacillus, is a frequent colonizer of fluids used in the hospital ward. It poses little risk of infection to healthy people; however it is a known important opportunistic pathogen causing morbidity and mortality due to its intrinsic resistance to most of the antibiotics in hospitalized patients. Small hospital outbreaks are frequent. B. cepacia may occur as an opportunistic infection in hemato-oncology patients. Here we present an outbreak of Burkholderia cepacia infection in hematology ward of our institute.
Methods: Febrile episodes as defined by IDSA guideline, 2010 were followed, and blood for culture and sensitivity was sent in all the events. The culture was done by an automated method using Bactalert 3d Biomeriux & sensitivity pattern by Microscan Siemens method and subsequently detected by PCR based method.
Results: During September 2016 to February 2017 (six months), a total of 498 blood cultures were sent during febrile episodes. Out of which 60 (12%) came out to be positive for different microorganisms. Out of all positive cultures, Burkholderia cepacia was detected in 29 (48%) patients, which reduced drastically following the change in antibiotic administration practice. All isolates showed sensitivity to pipercillin+tazobactum, cefoperazone+sulbactum, fluoroquinolones, cotrimoxazole and carbapenems and resistance to polymyxin B and colistin. With timely intervention by appropriate intravenous antibiotics as per culture sensitivity result and change in antibiotic preparation practice, overall mortality was low 1 (4%) out of 29 culture positive episodes.
Downloads month by month
2. Heo ST, Kim SJ, Jeong YG, et al. Hospital outbreak of Burkholderia stabilis bacteraemia related to contaminated chlorhexidine in haematological malignancy patients with indwelling catheters; J Hosp Infect 2008; 70: 241-45.
3. Baylan O. An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex. Mikrobiyol Bul 2012; 46: 304-18.
4. De Smet B, Veng C, Kruy L, et al. Outbreak of Burkholderia cepacia bloodstream infections traced to the use of Ringer lactate solution as multiple-dose vial for catheter flushing, Phnom Penh, Cambodia. Clin Microbiol Infect 2013; 19: 832-37.
5. T. Mann, D. Ben-David, A. Zlotkin, et al. An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients. Infection 2010; 38: 187–94.
6. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America; Clinical Infectious Diseases 2011; 52: e56–e93.
7. Lynch KH, Dennis JJ. Development of a Species-Specific fur Gene-Based Method for Identification of the Burkholderia Cepacia Complex. J Clin Microbiol 2008; 46: 447-55.
8. Abe K, D'Angelo MT, Sunenshine R, et al. Outbreak of Burkholderia cepacia bloodstream infection at an outpatient hematology and oncology practice. Infect Control Hosp Epidemiol 2007; 28: 1311–313.
9. Mandal PK, Maji SK, Dolai TK, et al. Micro-organisms Associated with Febrile Neutropenia in Patients with Haematological Malignancies in a Tertiary Care Hospital in Eastern India. Indian J Hematol Blood Transfus 2015; 31: 46–50.
10. Jones AM, Dodd ME, Govan JRW, et al. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 2004; 59: 948–51,.
11. Metan G, Demiraslan H, Kaynar LG, et al. Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases. Braz J Infect Dis 2013; 17: 143-9.
12. Burns JL, Wadsworth CD, Barry JJ, et al. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob Agents Chemother 1996; 40: 307-313.
13. Ledson MJ, Gallagher MJ, Corkill JE, Hart CA, Walshaw MJ; Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 1998; 53: 432-36.
14. Roy P, Ahmed NH, Biswal I, et al. Antimicrobial Susceptibility Pattern of Burkholderia cepacia Isolates from Patients with Malignancy. J Glob Infect Dis 2014; 6: 90–91.